Ibis T5000 News
Most Popular Ibis T5000 Story
Abbott shells out $215M for Isis unit
Abbott Laboratories has forged a deal to buy a unit of Isis Pharmaceuticals for $175 million--on top of a $40 million investment it made earlier this year. With its acquisition of Ibis Biosciences Read more...
Latest Headlines
- December 17, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
